ELDER PHARMA TIES UP WITH SWISS MAJOR TRB CHEM

The Rs 300 crore company, Elder Pharmaceuticals, has signed a strategic marketing alliance with the Swiss pharma major TRB Chemedica to introduce a new range of osteoarthritis and pain management drugs in India. This tie-up would enable the Mumbai-based company to make a foray into this therapeutic segment in India, as part of its business model based on strategic marketing alliances for launching new products in the market. With the strategic alliance with TRB, a market leader in the osteoarthritis segment in the European market, Elder would be licensed to manufacture one of the leading brands of the former Artrodar in India.

Business Standard (http://www.business-standard.com/common/storypage.php?storyflag=y&leftnm=lmnu1&leftindx=1&lselect=1&chklogin=N&autono=200276)